MINNEAPOLIS, May 30, 2024 /PRNewswire/ -- Bio-Techne
Corporation (NASDAQ: TECH) will showcase multiple applications of
its recently launched MauriceFlex™ System at the 72nd
ASMS Conference on Mass Spectrometry and Allied Topics, taking
place June
2nd-6th in Anaheim, California. The MauriceFlex system is
Bio-Techne's latest imaged capillary isoelectric focusing (icIEF)
solution, which enables icIEF-based fractionation in addition to
routine icIEF and capillary electrophoresis-sodium dodecyl sulfate
(CE-SDS) assays. By simplifying charge variant fraction collection,
the MauriceFlex system powers flexible downstream protein
characterization with various mass spectrometric (MS) methods. At
ASMS, Bio-Techne will feature a breakfast seminar and several
poster presentations to highlight its innovations in biomolecular
characterization.
![Bio-Techne Logo (PRNewsfoto/Bio-Techne Corporation) Bio-Techne Logo (PRNewsfoto/Bio-Techne Corporation)](https://mma.prnewswire.com/media/2380355/Bio_Techne_Logo.jpg)
The breakfast seminar titled "Solving the Challenges of Protein
Charge Heterogeneity Characterization using icIEF," will take place
on June 4th in Room 213A
of the Anaheim Convention Center.
During this session, Dr. Chris Heger
from Bio-Techne and Dr. Sara
Carillo from the National Institute for Bioprocessing
Research and Training will provide insights into applications of
the MauriceFlex system, including its unique ability to fractionate
charge isoforms in monoclonal antibodies, followed by downstream
characterization on various MS systems. The seminar will also
highlight the fractionation of AAV capsid proteins, demonstrating
the MauriceFlex system's suitability in cell and gene therapy
applications.
In addition to the seminar, Bio-Techne will present seven
posters, featuring collaborations with key industry partners
including Pfizer, 908 Devices, and more. These posters will detail
advances in charge isoform characterization of a variety of
molecules including AAVs and bispecific antibodies, showcasing
charge isoform fractionation followed by downstream
characterization methods such as CZE-MS, CD-MS, and LC-MS.
"Adding icIEF fractionation capability in the MauriceFlex system
enables our customers to combine icIEF with mass spectrometry
analysis, leading to a novel protein characterization approach. The
power of this unique capability is illustrated through a number of
collaborations highlighted at this year's ASMS conference," said
Will Geist, President of the Protein
Sciences Segment, Bio-Techne. "We are excited to engage scientists
with our seminar and posters and demonstrate our leadership in
protein characterization, so that they have all the tools needed to
create life-saving therapies for patients around the world."
Visit Bio-Techne at Booth #161 at ASMS! To learn more about the
MauriceFlex system, visit bio-techne.com/mauriceflex.
About Bio-Techne
Bio-Techne Corporation (NASDAQ:
TECH) is a global life sciences company providing innovative tools
and bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With thousands of
products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has
approximately 3,100 employees worldwide. For more information on
Bio-Techne and its brands, please visit http://www.bio-techne.com
or follow the Company on social media at Facebook, LinkedIn,
Twitter or YouTube.
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice
President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-highlight-multiple-applications-of-the-mauriceflex-system-at-the-annual-asms-conference-302154694.html
SOURCE Bio-Techne Corporation